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The Renaissance was the period that encom- 
passed the fourteenth, fifteenth, and sixteenth cen- 
turies. The Renaissance began in Florence, Italy, 
and gradually spread through Europe. The greatest 
achievements of the Renaissance came in scholar- 
ship and art. It was a period in history when the 
great feudal estates began to be broken up and 
people began to judge others on the basis of merit 
and not birth. The Renaissance lasted over 300 
years, and its achievements gradually became a part 
of everyday European life. 
In present day language, the term renaissance 
denotes a rebirth or revival. In the same way that the 
Renaissance gradually altered European society, the 
field of thoracic surgery has created evolutionary 
changes in medicine. As I look at the renaissance in
thoracic surgery, the first era extended from 1918 to 
1953. During this period thoracotomies were first 
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begun, pulmonary resections became routine, and 
tuberculosis became a surgically "curable" disease. 
Cardiac surgery remained an infant in the life of 
treatment for congenital heart disease and rheu- 
matic mitral stenosis. 
In my opinion, the founding of The American 
Association for Thoracic Surgery (AATS) in 1918 
historically marks the beginning of the renaissance 
in thoracic surgery. This renaissance began in New 
York City under the leadership of Dr. Willy Meyer, 
who practiced at the German Hospital which was 
renamed the Lennox Hill Hospital at the time of 
World War I. At the 1913 American Medical Asso- 
ciation Meeting in Minneapolis, Dr. Meyer pre- 
sented a paper on esophageal resection as per- 
formed by his associate, Dr. Franz Torek. It was the 
first successful resection of the esophagus for can- 
cer. The manuscript received no discussion. The 
lack of interest prompted Dr. Meyer and his associ- 
ates to organize two societies, the New York Society 
for Thoracic Surgery and the AATS. The word "for" 
thoracic surgery and not "of" thoracic surgery was 
chosen purposefully because of the inclusion of 
anatomists, anesthetists, internists, tuberculosis spe- 
cialists, radiologists, and endoscopists, as well as 
surgeons, who were invited to join the Association. 
There was considerable skepticism as to the suc- 
cess of such organizations because, at that time, 
there were few topics to discuss. Empyema, aneu- 
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rysm, bronchiectasis, and tumors of the chest wall 
were the subjects of interest. Only empyema pre- 
sented possibilities of surgical "cure." Lung cancer 
was uncommon, esophageal surgery impractical, 
treatment of tuberculosis only a fad, and everyone 
knew that surgery on the heart could not be done. 
Despite the extreme pessimism regarding the 
future of these organizations, they were formed. The 
first meeting of the AATS was held in 1918. Seventy 
percent of the members were from New York. In 
1922, arrangements were made with the Archives of 
Surgery to publish annually a special supplement 
devoted to the affairs of the Association: The first 
issue was printed in 1923. 
The renaissance spread from New York to Mich- 
igan in the early 1920s with John Alexander. Dr. 
Alexander went to the University of Michigan in 
1920. He wrote two books on tuberculosis, the first 
in 1925 entitled Surgery of Pulmonary Tuberculosis 
and the second in 1937 entitled The Collapse Ther- 
apy of Pulmonary Tuberculosis. In 1928 he devoted 
his full time to thoracic surgery and started the first 
thoracic surgical residency program. Dr. Alexander 
was a strong advocate of thoracoplasty for the 
treatment oftuberculosis. He popularized the three- 
stage removal of the upper seven ribs inasmuch as 
he demonstrated an increase in safety with this 
approach. Dr. Paul Samson, in whose name The 
Western Thoracic Surgical Association (WTSA) was 
founded, was Dr. Alexander's resident from 1934 to 
1936. 
The field of thoracic surgery continued to enlarge, 
and in 1931 THE JOURNAL OF THOgACIC SURGERY was 
founded with Evarts Graham as editor. The JOUR- 
NAL was bimonthly and the lead article in the first 
issue was read at the Fourteenth Annual Meeting of 
the AATS. The paper came from Peiping Union 
Medical College and was written by C. M. Van Allen 
and T. S. Jung. 1 It was entitled "Postoperative 
Atelectasis and Collateral Ventilation." The impor- 
tance of collateral ventilation was compared with 
that of collateral circulation. 
The 1930s were exciting times for the thoracic 
surgeon. In 1932, Dr. Deryl Hart, 2 the first chairman 
of the Department of Surgery at Duke University 
Medical Center, presented a paper entitled, "Treat- 
ment of Chronic Empyema by Tidal Irrigation, 
Suction, and Thoracoplasty." Dr. Graham's two- 
page discussion was critical of Dr. Hart's technique 
and outlined what he considered the principles 
of treatment of chronic empyema. Times have 
not changed! In 1933, Graham 3 performed the 
first successful pneumonectomy for cancer and 
Churchill 4 reported a bilobectomy with individual 
vessel igation. In 1935 Wangensteen 5 published on 
the use of pedicled muscle flaps for closure of a 
bronchopleural fistula, a technique still used today. 
In the same year, Overholt 6 emphasized the advan- 
tages of separate ligation of the hilar structures 
when performing pulmonary resection. Carl Egg- 
ers, 7 in his 1936 presidential address before the 
AATS, discussed the still pertinent question, "Who 
should perform thoracic surgery?" Should the prac- 
titioner be a general surgeon with some thoracic 
training, or should there be a specific training pro- 
gram for those who want to do thoracic surgery 
only? 
The 1930s also provided abackdrop for the novel 
idea that one might perform surgery on the heart. 
During the decade, Heinbecker s experimented with 
thoracic sympathectomy for "cardiac pain" or an- 
gina. Blum and Gross 9 reported on experimental 
coronary sinus ligation, Claude Beck 1° discussed 
methods to improve myocardial blood supply, and 
Bigger 1~ published a paper on surgery for heart 
wounds. In 1938, Gross became the first physician to 
successfully igate a patent ductus arteriosus) 2 The 
operation occurred 31 years after the operation of 
ductus ligation was suggested by John Munro. Dur- 
ing this period, thoracic surgery remained a compo- 
nent of general surgery. A committee appointed by 
the AATS in 1936 recommended that a separate 
board of thoracic surgery not be established. 13 
In 1941 Ochsner and DeBakey TM reported on the 
surgical aspects of carcinoma of the esophagus. 
They presented four cases and collected a total of 
195 cases with an operative mortality of 71.8%. This 
article contained more than 250 references. Surgery 
for tuberculosis was a major topic of discussion in 
the 1940s. Alexander, Sommer, and Ehler 15 advo- 
cated thoracoplasty asthe procedure of choice for 
tuberculosis complicated by stenotic bronchitis, and 
they believed that the need for lobectomy or pneu- 
monectomy in these cases was rare. Chamberlain ~6
supported thoracoplasty for upper lobe tuberculosis. 
Overholt and Wilson 17 believed the indications for 
lobectomy in tuberculosis were expanding and that 
the operative mortality in low-risk cases was only 
5.5%. In the late 1940s treptomycin was introduced 
as a chemotherapeutic agent for the treatment of 
tuberculosis. Clagett and Shepard is in 1943 re- 
ported on the treatment ofchronic empyema includ- 
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ing the use of muscle flaps to close a bronchopleural 
fistula and to fill the empyema cavity. Pneumonec- 
tomy for carcinoma of the lung was considered the 
procedure of choice but carried an operative mor- 
tality of about 25%. 19 
It is important to recognize that thoracic surgery 
until the mid-1940s consisted of what we now call 
general thoracic surgery. Interest in cardiac surgery 
was only minimal. In 1944, repair of coarctation of 
the aorta by Gross 2° in Boston and Crafoord and 
Nylin 21 in Sweden was accomplished. Dwight Har- 
ken 22 presented papers on experiments in intracar- 
diac surgery, and Harken, 23 Bailey, 24 and their col- 
leagues performed operations on stenosed mitral 
valves. Blalock 2s at Johns Hopkins performed his 
classic shunt procedures for tetralogy of Fallot. 
Although best remembered for his cardiac surgery 
and training of future surgical eaders, Blalock 26 
also reported on the relationship of the thymus 
gland to myasthenia gravis. 
World War II found the establishment of thoracic 
surgical centers. The treatment of thoracic wounds 
was reported by Samson, Burford, Brewer, and 
Burbank 27 and by Harken. 28 The principle of early 
decortication was advocated by Samson and associ- 
ates, 27 and these principles remain appropriate in 
modern practice. 
With the tremendous advances inthoracic surgery 
during the 1940s, the climate changed regarding 
whether or not a separate board of thoracic surgery 
should be formed. In 1948 the Board of Thoracic 
Surgery had its first organizational meeting as an 
affiliate of the American Board of Surgery. 
The 1950s were exciting for the thoracic surgeon. 
Thoracic surgery became general thoracic and car- 
diac surgery. Further eports on the surgical treat- 
ment of mitral stenosis were published by Harken 
and Bailey. Atrial septal defects were repaired by a 
number of closed techniques. Henry Swan from 
Denver was one of the leaders in the use of hypo- 
thermia nd inflow occlusion. He repaired 100 atrial 
septal defects with only seven deaths and none in 
the last 57 cases. 29 Cross circulation provided an- 
other method to repair these defects. 
The second era in the thoracic surgery renais- 
sance began in May of 1953, when John Gibbon first 
successfully closed an atrial septal defect with the 
use of cardiopulmonary b pass. It is little remem- 
bered that Clarence Dennis attempted the same 
procedure using cardiopulmonary b pass in 1951, 
but the patient did not survive. In 1957 Kirklin and 
colleagues 3° reported on the surgical correction of 
ventricular septal defects in 36 patients with the use 
of cardiopulmonary b pass. Coronary insufficiency 
remained a topic of interest, and Arthur Vineberg 31 
from Montreal was a proponent of left internal 
mammary implantation into the left ventricular 
myocardium, a procedure he had performed in 
experimental nimals in the 1940s. 
General thoracic surgery was not without ad- 
vances in the 1950s. Tuberculosis was still a fre- 
quently discussed topic, and isoniazid and para- 
aminosalicylic acid were added to streptomycin for 
medical therapy. An increasing number of patients 
underwent pulmonary resection for tuberculosis 
rather than thoracoplasty with excellent results 
now that antibiotic overage was available. Viking 
Bj6rk, perhaps better known for his cardiac surgery, 
published articles on resection and osteoplastic 
thoracoplasty for tuberculosis. In 1957 he 32 reported 
on 301 lobectomies with an operative mortality 
of only 2.3%. Ninety-four percent of the patients 
had a concomitant space-diminishing procedure 
performed. 
Samson continued to write about decortication. 
Robinson, Jones, and Meyer 33 reported on a series 
of patients and demonstrated better survival for 
lobectomy versus pneumonectomy in carcinoma of 
the lung. Meyer also surveyed surgeon members of 
the AATS and found that about 60% used lobec- 
tomy as the operation of choice in treating lung 
carcinoma. The esophagus received more attention 
in the 1950s. Collis 34 reported on an operation for 
hiatus hernia with short esophagus. Olsen, Schlegel, 
Creamer, and Ellis 3s wrote about achalasia, and 
Neville and Clowes 36 reported on colon replace- 
ment of the esophagus. 
In 1953 a second major society, the Southern 
Thoracic Surgical Association (STSA), was founded. 
In 1950 THE JOURYAI. ov THORACm SURGERY became 
a monthly publication. The JOUt~,~AI~ underwent a 
name change to become THE JOURNAL OF THORACIC 
AND CARDIOVASCULAR SURGERY in 1959, thus recog- 
nizing the obvious advances in cardiovascular sur- 
gery. 
In the 1960s the thoracic surgeon became a 
cardiothoracic surgeon with emphasis on the cardiac 
aspect. The first heart valve was successfully re- 
placed in its native position by Dr. Albert Starr, and, 
after Mason Sones developed coronary angiogra- 
phy, the coronary artery bypass era was begun. The 
first coronary artery bypass, though unsuccessful, 
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was performed by Dr. David Sabiston in 1962. Heart 
transplantation was successfully performed in 1967 
and has become aroutine procedure throughout the 
country. With the increase in cardiothoracic surgery, 
a second national organization, The Society of Tho- 
racic Surgeons (STS), was formed in 1964. Shortly 
thereafter, The Annals of Thoracic Surgery began 
publication with'John D. Steele as its first editor. 
During the 1970s most horacic training programs 
emphasized cardiac surgery rather than general 
thoracic surgery. This was the beginning of an era in 
which coronary artery bypass dominated the field of 
thoracic surgery. Improvements in valve prostheses, 
myocardial preservation, and cardiopulmonary b - 
pass techniques were forthcoming. General thoracic 
surgery received less attention, although Samson 37 
continued to write about decortication and gave 
Dave Dugan, one of the founders of the WTSA, 
credit for introducing the word empyemectomy. 
The Board of Thoracic Surgery became aprimary 
board, rather than an affiliate of the American 
Board of Surgery, in 1971, and it became the 
American Board of Thoracic Surgery (ABTS). The 
Samson Thoracic Surgical Association was founded 
in 1974 under the leadership of Dave Dugan and Art 
Thomas and was renamed The Western Thoracic 
Surgical Association (WTSA) in June 1983. 
Coronary artery angioplasty was introduced in the 
late 1970s by Andreas Grunzig and associates. 38 
Throughout the 1980s and into the 1990s, angio- 
plasty mushroomed into a common procedure in 
most catheterization laboratories. The 1980s and 
1990s have produced refinements in all areas of 
thoracic and cardiac surgery. Lung transplantation 
became a reality after Cooper and the Toronto 
group performed the first successful transplant in 
1983, 20 years after James Hardy introduced the 
procedure. 
During this era the once inoperable organ, the 
heart, ceased to be inoperable. The repair of con- 
genital defects, valvular lesions, coronary obstruc- 
tions, rhythm disturbances, and transplantation 
dominated the practice of thoracic surgery. Concur- 
rently, the treatment of obstructive coronary artery 
disease in the catheterization laboratory exploded 
and the previous check and balance system where 
cardiologists diagnosed and surgeons operated was 
markedly altered. General thoracic surgery, al- 
though not ignored uring this second phase of the 
renaissance of thoracic surgery, certainly took a 
back seat, and individuals who wanted to dedicate 
most of their efforts to general thoracic surgery 
became more scarce. 
The founding of the General Thoracic Surgical 
Club initiates the current era in the renaissance in
thoracic surgery. This organization began in 1988 
with its leadership coming from the Mayo Clinic and 
general thoracic surgeons from other institutions. 
Membership was for thoracic surgeons whose pri- 
mary practice was general thoracic surgery. Much 
has happened in thoracic surgery during the past 6 
years and changes in our specialty reflect some of 
the changes going on in medicine in this country. 
As of 1994 there are 93 thoracic surgical training 
programs approved by the Residency Review Com- 
mittee. Seventy-three p rcent are 2-year programs 
with the remainder encompassing 21/2 or 3 years. 
Almost 150 residents finish their training annually. 
Separate rotations in general thoracic surgery are in 
62% of the programs, 52% have separate rotations 
in adult cardiac surgery, and 60% have separate 
rotations in pediatric ardiac surgery. 
It is unlikely in view of the current climate in 
medicine to expect an increase in training programs 
or an increased number of residents in existing 
programs oon. Regardless of which health care 
program eventually comes to pass, we will be fortu- 
nate to keep the same numbers of resident positions 
we have now, and there might be less demand for 
our services. 
The Thoracic Surgical Directors Association 
(TSDA) has received its wake-up call and has 
become appropriately active. The TSDA now ap- 
points two members to the ABTS. The TSDA is 
making an effort to revise the thoracic surgical 
training curriculum and has obtained 100% partici- 
pation in the Thoracic Residency Match. It is of 
interest, however, that few members of the TSDA 
are full-time general thoracic surgeons. John Ben- 
field, who is a past president of the WTSA and 
president-elect of the STS, and Mark Orringer, who 
will deliver the Lyman A. Brewer III Lecture at this 
year's WTSA meeting, are two of these individuals. 
A few programs have joint directorships--one di-
rector being a cardiac and the other a general 
thoracic surgeon. Some members of the TSDA 
consider themselves tobe both cardiac and general 
thoracic surgeons. 
The ABTS, as it is today, functions for the pri- 
mary purpose of protecting the public through the 
establishment and maintenance of standards in tho- 
racic surgery. These standards are measured via 
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written and oral certifying examinations. At present, 
certificates are valid for 10 years after which a 
recertification examination can be taken, which is 
valid for 10 more years. The written and oral 
examinations are reviewed yearly and undergo con- 
tinuous revision to improve their quality and psy- 
chometric validity. 
As far as pediatric ardiac surgery is concerned, 
corrective and palliative surgery is being performed 
on increasingly ounger patients. The ABTS has 
decreased certification requirements from 25 to 20 
pediatric cardiac cases. It has also changed the 
distribution from 15 open and 10 closed cases to 
simply 20 cases regardless of whether they are open 
or closed. Additionally, 155 index cases in other 
areas of cardiac surgery and general thoracic surgery 
are required before the applicant is permitted to 
take the Board examination. Through the end of 
1993, 5441 certificates have been issued and more 
than 4700 certified thoracic surgeons are practicing 
in the world. 
Thoracic surgeons have two national societies, the 
AATS and STS, and two regional societies, the 
WTSA and STSA. Papers presented at these meet- 
ings are published in Trm JouayaI~ oz THORACIC AND 
CARI~IOVASCUI.AR SUR6ERY, whose editorial leader- 
ship is being passed from John Kirklin to John 
Waldhausen, and The Annals of Thoracic Surgery, 
edited by Tom Ferguson. Papers presented at the 
General Thoracic Surgical Club are not published 
currently because they include general reviews of 
major topics or data that have been recently pre- 
sented or will be presented. 
The STS National Database has been established 
and now has 10 years of adult cardiac data. As of 
January 1994, more than 344,000 patients have been 
entered in the system from approximately 600 hos- 
pitals and 1235 surgeons. For first-time elective 
coronary artery bypass with an internal mammary 
artery, mortality from 1991 to 1993 is 1.38%. During 
the same period, emergency operations inwhich the 
internal mammary artery was used had an operative 
mortality of 2.5%. Overall mortality for aortic valve 
replacement during a similar period was 3.12% and 
for mitral valve replacement, 5.27%. Similar superb 
results are now being obtained at most institutions 
for bypass procedures with concomitant valve repair 
or replacement, valve repair alone, or with other 
forms of intracardiac surgery in adults. 
Despite the excellent results, debate still rages 
regarding cardioplegia. Meetings and symposia re 
held with faculties of up to 30 distinguished physi- 
cians to discuss the merits of cold versus warm, 
antegrade versus retrograde, or both. When this 
issue is decided, we dump in various additives and 
substrates. There are even individuals who do not 
use cardioplegia and report marvelous results, which 
I interpret as meaning that cardioplegia is not all 
that important or that the perfect combination of 
what solution given in what manner for what clinical 
situation at what temperature still has not been 
decided. At least for the present, the cardioplegia 
question provides interesting literature and an ex- 
cuse for another meeting. 
A continuous battle is being waged between car- 
diac surgeons and invasive cardiologists with their 
angioplasty catheters, lasers, atherectomy instru- 
ments, and stents. The cardiologic or surgical pro- 
cedure performed is often not determined by clear 
indications or data, but by the aggressiveness of the 
cardiologic team. 
I have not made mention of electrophysiologic 
surgery. The pioneering work of Will Sealy while at 
Duke University and Jim Cox now at Barnes Hos- 
pital in St. Louis is recognized worldwide as having 
provided an additional tool for the cardiac surgeon. 
Cardiac transplantation, originally pioneered in 
Minnesota nd at Stanford, is now performed with 
low operative mortality at most medical centers. 
Similarly, the treatment of dissecting aneurysms has 
become a routine operative procedure, with Craig 
Miller, our president-elect, a leading authority. 
In general thoracic surgery, current interest is in 
the use of neoadjuvant therapy for treatment of 
carcinoma of the lung, the leading killer from neo- 
plastic disease in the United States. Cooperative 
studies under the auspices of such acronyms as the 
LCSG, ECOG, and SWOG have been carried out 
with results that show an increased survival with this 
combined form of therapy in some stages of the 
disease. Likewise, with carcinoma of the esophagus, 
neoadjuvant therapy seems to offer some benefit. 
Differences in the approach to esophageal carci- 
noma among Drs. Orringer, DeMeester, Skinner, 
and others exist at present, and the ultimate answer 
as to what is the best form of therapy is still not 
clear. 
Lung transplantation has continued to grow. Coo- 
per's move to St. Louis with Patterson has made 
their institution an instant leader in the field. Other 
centers have actively joined the transplantation 
field. When Trinkle from San Antonio introduced 
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telescoping of the bronchial anastomosis, this por- 
tion of the operation was simplified. 
We in Denver have played a role in the recent 
therapy for tuberculosis, which has seen a resur- 
gence since 1985. Over 26,000 new cases a year now 
occur in the United States, about 10% of which are 
due to resistant organisms. Surgery is now indicated 
for resistant organisms and localized disease. We 
have operated on approximately 200 patients with 
pulmonary mycobacterial disease, half for resistant 
tuberculosis and the remainder for other mycobac- 
terial infections, with mortality rates of 2% to 3%. 
Results have been better than with medical manage- 
ment alone. Because 3,000,000 deaths occur world- 
wide yearly from tuberculosis, this disease cannot be 
ignored despite a recent report showing a slight 
decline in the United States. 
Discussion of general thoracic surgery would not 
be complete without mention of video-assisted tho- 
racic surgery (VATS). The VATS doctors have 
inundated the literature and reinvented each and 
every thoracic operation with cameras and instru- 
ments inserted via tiny incisions. Although no great 
scientific discoveries have come from VATS, it adds 
another dimension to general thoracic surgery, re- 
duces pain, and in some procedures reduces hospital 
stay. 
This is the way I see thoracic surgery today. Of 
greater significance iswhat is in store for the future. 
It is somewhat presumptuous of me to comment on 
this subject, because ajoint conference on graduate 
education in thoracic surgery was held in September 
of 1992. 39 First of all, all gross technical advances in 
cardiac surgery have been made. The heart has been 
repaired in part or in toto, new plumbing has been 
added, valves have been replaced, and the conduc- 
tion system has been rerouted to a point far beyond 
what was dreamed possible 41 years ago during the 
first successful cardiopulmonary b pass. 
Similarly, the most obvious technical advances in 
general thoracic surgery have occurred, and VATS 
will find its rightful place. A rebirth in general 
thoracic surgery interest has blossomed along with 
VATS, but not solely because of VATS. Unfortu- 
nately, approximately one third of the residency 
programs in the United States do not have a dedi- 
cated general thoracic surgeon, a situation that 
impedes progress of this portion of thoracic surgery. 
The treatment of malignant horacic disease will 
continue to evolve through neoadjuvant, other che- 
motherapeutic, and still greater scientific advances. 
Transplantation fcardiothoracic organs will con- 
tinue to develop. Better antirejection drugs and 
regimens will be found, but it is more likely that 
manipulation of the immune system, or transgenic 
tolerance, will provide the answers of the future. 
The relationship of chimerism to tolerance, as re- 
ported from Pittsburgh, remains to be established. 
The most important future direction in thoracic 
surgery is molecular biology. The same is true of 
other branches of medicine. To support his conten- 
tion one simply has to look at the basic science 
lecture of the 1993 AATS meeting given by Dr. 
Andrew Wechsler, entitled, "Molecular Biology: 
New Common Ground for Cardiothoracic Surgery." 
Furthermore, the Lyman A. Brewer III Lecture to 
be presented at this meeting by Drs. Mark Orringer 
and David Beer, entitled, "Carcinoma of the Esoph- 
agus from Molecular Biology to Surgery," further 
supports this belief. Specific genetic mutations are 
noted almost daily in malignant disease and other 
inherited thoracic disorders. Manipulation of the 
genetic system will obviously play a part in the 
treatment of thoracic diseases in the future. 
Let me address residency training in thoracic 
surgery. I have little to say that will be new or 
original. With so few thoracic surgeons, splitting 
cardiac from general thoracic surgery seems coun- 
terproductive. The so-called "splitters," though oc- 
casionally vocal, add little to benefit thoracic sur- 
gery. The thoracic surgeon must be well trained in 
all areas of thoracic surgery, and to do this in less 
than 3 years seems impossible. John Alexander's 
first thoracic surgical training program began in 
1928 and was a 2-year program. Dr. Alexander 
believed that after being trained in general surgery, 
a surgeon required 2 additional years of training to 
become a thoracic surgeon. Although some general 
thoracic procedures are no longer performed fre- 
quently, others have been substituted, and with 
cardiac surgery and transplantation, I certainly be- 
lieve 3 years of thoracic training is warranted. Many 
discussions are going on between the leadership in 
general surgery and thoracic surgery as to how this 
can be accomplished without increasing the length 
of residency. Furthermore, to have a resident in a 
2-year thoracic program spend a portion of the first 
year studying for general surgery boards diminishes 
the value of that year, and this problem needs to be 
resolved. 
It is the responsibility of the TSDA in these 
rapidly changing times of thoracic surgery to contin- 
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uously update the thoracic surgery curriculum. It is 
unacceptable to have a resident spend most of his 
time doing coronary artery bypass urgery when he 
should have a broader view of the ever changing 
field of thoracic surgery. It is also the joint respon- 
sibility of the TSDA and the ABTS to be in constant 
communication so that the certifying examination is 
truly reflective of the contemporary curriculum. 
Fortunately, many of the members of the TSDA also 
serve on the ABTS. Lastly, residency programs must 
become more flexible. Each resident should be 
exposed to broad basic training in thoracic surgery. 
The trainee may want to be a transplant surgeon, 
pediatric cardiac surgeon, adult cardiac surgeon, 
general thoracic surgeon, or a combination of these 
disciplines. We must be flexible enough to accom- 
modate these wishes and possibly use the third yea r
of thoracic training to accomplish this goal. 
The TSDA must have a broader epresentation in 
general thoracic surgery and must continue to sup- 
port the principle of having a dedicated general 
thoracic surgeon in each program. The problem of 
numbers in thoracic surgery must be mentioned 
again. It is doubtful that residency programs will 
enlarge. Whether we have too many thoracic sur- 
geons cannot be answered, because we do not know 
if rationing of health care will be a factor or if new 
technology will increase or decrease the need for 
our collective services. It is certain, however, that 
there are not enough general thoracic surgeons. Too 
much of general thoracic surgery done in the com- 
munity is performed by noncertified, inadequately 
trained physicians. Greater use of physician extend- 
ers, be they nurse practitioners or physician assis- 
tants, should be anticipated in academic and private 
practice. 
The spirit of cooperation i our societies appears 
to be better than when I began my practice 27 years 
ago. This cooperation includes research interests, 
practice guidelines, and dealing with the federal 
government, which is so anxious to regulate us. The 
work in this latter area by George Miller and now 
Jack Matloff should be appreciated by all thoracic 
surgeons. 
Is there a renaissance? I believe there is. It began 
in 1918 and continues today. Whereas the classical 
Renaissance was in scholarship and art, the renais- 
sance in thoracic surgery involves technical innova- 
tion and science. In the early thoracic renaissance, 
surgeons dared to operate on the lung or esophagus 
with mortalities of 50% or greater. Mortality grad- 
ually decreased to under 5% for most general 
thoracic surgical procedures. Then came cardiac 
surgery. From 1953 to 1988 more emphasis was 
placed on cardiac surgery than general thoracic 
surgery. At present, cardiac surgery can be per- 
formed with mortalities at or below 5% for most 
elective procedures. For the renaissance to con- 
tinue, we must move forward in all areas of thoracic 
surgery. General thoracic surgery should receive 
appropriate mphasis in all training programs, and 
since 1988 this fact appears to be appreciated by the 
leadership in thoracic surgery. 
Many enigmatic problems in general thoracic 
surgery remain. Postpneumonectomy pulmonary 
edema, described and published extensively by Dick 
Peters, 4° remains almost uniformly fatal. Why pa- 
tients with blood group type A have a better likeli- 
hood of survival when treated for carcinoma of the 
lung remains apuzzlement. Findings uch as a K-ras 
mutation predicting a worse prognosis and muta- 
tions in the p53 gene predicting lower survival are 
interesting but are not yet of clinical benefit. 
Future directions of research will be in the area of 
molecular biology. Finding genetic and molecular 
biologic alterations in disease must be translated 
into clinical relevance. Much is left to be done by the 
next generations of thoracic surgeons. They will 
have to be knowledgeable in basic science, as well as 
in the techniques of thoracic surgery. 
General thoracic surgery has been understand- 
ably ignored in many thoracic training programs 
because of the rapid and exciting advances in car- 
diac surgery. In many programs, esophageal work is 
done by the general surgeons and traumatic hest 
injuries are managed by the "trauma surgeon." 
These areas must be brought back into thoracic 
surgical training programs. As pointed out by Ben- 
f ieldy to render the best care, thoracic surgeons 
must be available and be involved in the manage- 
ment of thoracic trauma. The cardiac portion of 
thoracic surgery faces similar problems. Genetic 
manipulation and changes at the molecular biologic 
level offer the next frontier to conquer. The perfect 
algorithm for cardioplegia will be written. 
Historically the Renaissance was an ongoing phe- 
nomenon that lasted more than 300 years. Thoracic 
surgery likewise has been evolutionary, with dra- 
matic changes and developments since 1918. Dr. 
John Alexander in Michigan is the person most 
responsible for the orderly development of thoracic 
surgery. He trained 80 surgeons who disseminated 
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thoracic surgical knowledge throughout the country. 
With the development of cardiovascular surgery, 
there were significant alterations in thoracic surgery. 
Cardiac surgery dominated most training programs, 
as well as the clinical practice of thoracic surgery, 
during the past 40 years. In a literal sense, there has 
been a revival or renaissance in general thoracic 
surgery over the past 5 to 6 years. This will have to 
continue for a balance in our residency programs to 
be maintained. 
The thoracic surgery renaissance will and should 
continue. Molecular biology and genetic manipula- 
tions are the next frontier. Thoracic surgeons will 
play a significant role in these disciplines of the 
future. 
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